OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation
Haryana Y. Thomas, Ashlee N. Ford Versypt
Journal of Biological Engineering (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 81
Haryana Y. Thomas, Ashlee N. Ford Versypt
Journal of Biological Engineering (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 81
Showing 1-25 of 81 citing articles:
Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review
Shiwan Hu, Hang Xing, Yu Wei, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Shiwan Hu, Hang Xing, Yu Wei, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Autophagy and its therapeutic potential in diabetic nephropathy
Yu-Peng Han, Lijuan Liu, Jia-Lin Yan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
Yu-Peng Han, Lijuan Liu, Jia-Lin Yan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 28
An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory
Tongyue Yang, Qi Feng, Feng Guo, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 13
Tongyue Yang, Qi Feng, Feng Guo, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 13
tRF3-IleAAT reduced extracellular matrix synthesis in diabetic kidney disease mice by targeting ZNF281 and inhibiting ferroptosis
Yunyang Qiao, Jialing Ji, Wei-ling Hou, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 1032-1043
Closed Access | Times Cited: 9
Yunyang Qiao, Jialing Ji, Wei-ling Hou, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 1032-1043
Closed Access | Times Cited: 9
Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: An in vitro study
Haleema Shahin DH, Rokeya Sultana, Ashwini Prabhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116533-116533
Open Access | Times Cited: 8
Haleema Shahin DH, Rokeya Sultana, Ashwini Prabhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116533-116533
Open Access | Times Cited: 8
Beyond Redox Regulation: Novel Roles of TXNIP in the Pathogenesis and Therapeutic Targeting of Kidney Disease
Chuang Li, Yili Fang, Ying Maggie Chen
American Journal Of Pathology (2025)
Closed Access | Times Cited: 1
Chuang Li, Yili Fang, Ying Maggie Chen
American Journal Of Pathology (2025)
Closed Access | Times Cited: 1
Upregulation of Piezo2 and increased extracellular matrix protein in diabetic kidney disease mice
Rina Oba, Hitoshi Ueno, Atsuro Oishi, et al.
Hypertension Research (2025)
Closed Access | Times Cited: 1
Rina Oba, Hitoshi Ueno, Atsuro Oishi, et al.
Hypertension Research (2025)
Closed Access | Times Cited: 1
The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
Liang‐Jun Yan
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1225-1225
Open Access | Times Cited: 34
Liang‐Jun Yan
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1225-1225
Open Access | Times Cited: 34
The complex pathology of diabetic nephropathy in humans
Wilhelm Kriz, Jana Löwen, Hermann‐Josef Gröne
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 10, pp. 2109-2119
Open Access | Times Cited: 19
Wilhelm Kriz, Jana Löwen, Hermann‐Josef Gröne
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. 10, pp. 2109-2119
Open Access | Times Cited: 19
The Potential of DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus
Jonny Jonny, Enda Cindylosa Sitepu, I Nyoman Ehrich Lister, et al.
(2024)
Open Access | Times Cited: 5
Jonny Jonny, Enda Cindylosa Sitepu, I Nyoman Ehrich Lister, et al.
(2024)
Open Access | Times Cited: 5
Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
Linlin Sun, Miao Ding, Fuhua Chen, et al.
PeerJ (2023) Vol. 11, pp. e14826-e14826
Open Access | Times Cited: 12
Linlin Sun, Miao Ding, Fuhua Chen, et al.
PeerJ (2023) Vol. 11, pp. e14826-e14826
Open Access | Times Cited: 12
Diagnostic challenges of diabetic kidney disease
Lea Smirčić Duvnjak, Sandra Božičević, Marijana Vučić Lovrenčić
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 227-241
Open Access | Times Cited: 12
Lea Smirčić Duvnjak, Sandra Božičević, Marijana Vučić Lovrenčić
Biochemia Medica (2023) Vol. 33, Iss. 3, pp. 227-241
Open Access | Times Cited: 12
AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy
Meng Yang, Jialin Li, Xiaocui Huang, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108184-108184
Closed Access
Meng Yang, Jialin Li, Xiaocui Huang, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108184-108184
Closed Access
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin
Anna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1088-1088
Open Access
Anna Szeremeta, Agnieszka Jura-Półtorak, Alicja Grim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1088-1088
Open Access
Association between neutrophil-percentage-to-albumin ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study from NHANES 2009–2018
Hongying Li, Yue Xu, Shuhan Fan, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Hongying Li, Yue Xu, Shuhan Fan, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors
Wenwen Guo, Han Li, Yixuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115025-115025
Open Access | Times Cited: 9
Wenwen Guo, Han Li, Yixuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115025-115025
Open Access | Times Cited: 9
Kidney Considerations in Pediatric Obesity
Alexandra Sawyer, Evan Zeitler, Howard Trachtman, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 332-344
Closed Access | Times Cited: 9
Alexandra Sawyer, Evan Zeitler, Howard Trachtman, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 332-344
Closed Access | Times Cited: 9
Cross-Domain Text Mining of Pathophysiological Processes Associated with Diabetic Kidney Disease
Krutika Patidar, Jennifer Deng, Cassie S. Mitchell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Krutika Patidar, Jennifer Deng, Cassie S. Mitchell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Scopoletin alleviates high glucose-induced toxicity in human renal proximal tubular cells via inhibition of oxidative damage, epithelial-mesenchymal transition, and fibrogenesis
Sourav Kundu, Sitara Ghosh, Bidya Dhar Sahu
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Sourav Kundu, Sitara Ghosh, Bidya Dhar Sahu
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway
Keqian Wu, He Zha, Tianhui Wu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Keqian Wu, He Zha, Tianhui Wu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease
Ignacio Priéto, María Kavanagh, Luna Jiménez-Castilla, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102041-102041
Open Access | Times Cited: 8
Ignacio Priéto, María Kavanagh, Luna Jiménez-Castilla, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102041-102041
Open Access | Times Cited: 8
N6-methyladenosine methylation in kidney injury
Qimeng Wang, Xiaoting Fan, Qinghao Sheng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Qimeng Wang, Xiaoting Fan, Qinghao Sheng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Renal MRI : From Nephron to NMR Signal
Octavia Bane, Erdmann Seeliger, Eleanor Cox, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 58, Iss. 6, pp. 1660-1679
Open Access | Times Cited: 7
Octavia Bane, Erdmann Seeliger, Eleanor Cox, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 58, Iss. 6, pp. 1660-1679
Open Access | Times Cited: 7
Intestinal Absorption of Nanoparticles to Reduce Oxidative Stress and Vasoconstriction for Treating Diabetic Nephropathy
Chenxin Liu, Mengxue Pang, Qingyu Wang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1517-1529
Closed Access | Times Cited: 2
Chenxin Liu, Mengxue Pang, Qingyu Wang, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1517-1529
Closed Access | Times Cited: 2
Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway
Bangrui Huang, Rui Han, Hong Tan, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Bangrui Huang, Rui Han, Hong Tan, et al.
Natural Products and Bioprospecting (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
